levofloxacin has been researched along with Burkholderia pseudomallei Infection in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, YY; Chua, KL; Ong, YM | 1 |
| Chen, CH; Chi, CY; Chou, CH; Ho, MW; Hsih, WH; Hsueh, PR; Lin, HH; Lin, YT; Tseng, KH; Wu, PH | 1 |
| Hong-Geller, E; Micheva-Viteva, S; Ross, BN; Torres, AG | 1 |
| Butcher, W; D'Elia, RV; Khadke, S; McGahon, J; Perrie, Y; Roberts, CW; Williamson, ED; Woods, S | 1 |
| Ader, F; Conrad, A; Ferry, T; Valour, F | 1 |
5 other study(ies) available for levofloxacin and Burkholderia pseudomallei Infection
| Article | Year |
|---|---|
Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei.
Topics: Anti-Infective Agents; Burkholderia pseudomallei; Cells, Cultured; Drug Synergism; Humans; Lung; Macrophages; Melioidosis; Microbial Sensitivity Tests; Phenothiazines; Proton Pump Inhibitors | 2007 |
Emergence of meropenem and levofloxacin resistance in Burkholderia pseudomallei in Taiwan.
Topics: Anti-Bacterial Agents; Burkholderia pseudomallei; Humans; Levofloxacin; Melioidosis; Meropenem; Taiwan | 2023 |
Evaluating the role of Burkholderia pseudomallei K96243 toxins BPSS0390, BPSS0395, and BPSS1584 in persistent infection.
Topics: Animals; Anti-Bacterial Agents; Burkholderia pseudomallei; Cell Line; Female; Levofloxacin; Melioidosis; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; RAW 264.7 Cells; Toxins, Biological | 2019 |
Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bile Acids and Salts; Burkholderia pseudomallei; Doxycycline; Drug Delivery Systems; Female; Levofloxacin; Melioidosis; Mice; Mice, Inbred BALB C | 2019 |
Multifocal melioidosis with femoral osteomyelitis in a healthy 25-year-old traveller.
Topics: Adult; Anti-Bacterial Agents; Burkholderia pseudomallei; Ceftazidime; Doxycycline; Female; Femur; Humans; Levofloxacin; Magnetic Resonance Imaging; Melioidosis; Osteomyelitis; Positron Emission Tomography Computed Tomography; Travel; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |